Skip to main content
. 2023 Feb 7;14:105–110. doi: 10.18632/oncotarget.28360

Figure 1.

Figure 1

Comparison of progression-free survival (A) and overall survival (B) between children (<15 years) versus adolescents and young adults (AYAs ≥15 years) with WNT-pathway medulloblastoma.